World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
10000
World Ranking
4677
National Ranking
222

Mustapha Si-Tahar publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mustapha Si-Tahar sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 137 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mustapha Si-Tahar D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mustapha Si-Tahar sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mustapha Si-Tahar is affiliated with François Rabelais University in France. Their research spans medicine, immunology, and microbiology, with particular focus in subfields such as immunology, pulmonary and respiratory medicine, infectious diseases, epidemiology, and molecular biology.

Their work frequently addresses topics including:

  • Immune Cell Function and Interaction
  • Immune Response and Inflammation
  • Influenza Virus Research Studies
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory Support and Mechanisms
  • Immune cells in cancer

Among the recent publications authored by or involving Mustapha Si-Tahar are:

  • Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity, 2021, Nature Immunology
  • Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients, 2020, The Journal of Experimental Medicine
  • High Dimensional Single-Cell Analysis Reveals iNKT Cell Developmental Trajectories and Effector Fate Decision, 2020, Cell Reports
  • Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein, 2022, The EMBO Journal
  • Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS, 2021, Critical Care

Frequent co-authors collaborating with Mustapha Si-Tahar include:

  • Antoine Guillon
  • Christophe Paget
  • Adeline Cezard
  • Virginie Vasseur
  • Thomas Baranek

Publications have appeared repeatedly in venues such as:

  • Revue des Maladies Respiratoires
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Cystic Fibrosis
  • The EMBO Journal
  • 10.01 - Respiratory infections and bronchiectasis

Best Publications

  • Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus *

    Loïc Guillot;Ronan Le Goffic;Sarah Bloch;Nicolas Escriou

  • Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.

    Ronan Le Goffic;Ronan Le Goffic;Viviane Balloy;Viviane Balloy;Micheline Lagranderie;Lena Alexopoulou;Lena Alexopoulou

  • In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells

    Matthias Lochner;Lucie Peduto;Marie Cherrier;Shinichiro Sawa

  • Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells.

    Ronan Le Goffic;Ronan Le Goffic;Julien Pothlichet;Julien Pothlichet;Damien Vitour;Takashi Fujita

  • Response of Human Pulmonary Epithelial Cells to Lipopolysaccharide Involves Toll-like Receptor 4 (TLR4)-dependent Signaling Pathways EVIDENCE FOR AN INTRACELLULAR COMPARTMENTALIZATION OF TLR4

    Loïc Guillot;Samir Medjane;Karine Le-Barillec;Viviane Balloy

  • Cutting Edge: The Immunostimulatory Activity of the Lung Surfactant Protein-A Involves Toll-Like Receptor 4

    Loïc Guillot;Viviane Balloy;Francis X. McCormack;Douglas T. Golenbock

  • Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells

    Matthias Lochner;Caspar Ohnmacht;Caspar Ohnmacht;Laura Presley;Laura Presley;Pierre Bruhns;Pierre Bruhns

  • Innate sensing of HIV-infected cells.

    Alice Lepelley;Stephanie Louis;Marion Sourisseau;Helen K. W. Law

  • Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6

    Shanthi V. Sitaraman;Didier Merlin;Lixin Wang;Michelle Wong

  • Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: Transport of bacterial peptides influences expression of MHC class 1 molecules

    Didier Merlin;Mustapha Si-Tahar;Shanthi V. Sitaraman;Karen Eastburn

  • Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.

    Héloïse Flament;Héloïse Flament;Matthieu Rouland;Lucie Beaudoin;Amine Toubal

  • Cutting Edge: Innate Immune Response Triggered by Influenza A Virus Is Negatively Regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-Dependent Pathway

    Julien Pothlichet;Michel Chignard;Mustapha Si-Tahar

  • Interleukin-22 Is Produced by Invariant Natural Killer T Lymphocytes during Influenza A Virus Infection: POTENTIAL ROLE IN PROTECTION AGAINST LUNG EPITHELIAL DAMAGES*

    Christophe Paget;Stoyan Ivanov;Josette Fontaine;Joelle Renneson

  • Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.

    Youenn Jouan;Antoine Guillon;Antoine Guillon;Loïc Gonzalez;Loïc Gonzalez;Yonatan Perez;Yonatan Perez

  • Interleukin-22 Reduces Lung Inflammation during Influenza A Virus Infection and Protects against Secondary Bacterial Infection

    Stoyan Ivanov;Joelle Renneson;Josette Fontaine;Adeline Barthelemy

  • Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor.

    Patricia Renesto;Mustapha Si-Tahar;Marc Moniatte;Viviane Balloy

  • Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation

    Karine Le-Barillec;Mustapha Si-Tahar;Viviane Balloy;Michel Chignard

  • Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

    Reuben Ramphal;Viviane Balloy;Viviane Balloy;Jeevan Jyot;Amrisha Verma

  • Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.

    Viviane Balloy;Mustapha Si-Tahar;Osamu Takeuchi;Bruno Philippe

  • A loss‐of‐function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients

    Julien Pothlichet;Julien Pothlichet;Julien Pothlichet;Timothy B. Niewold;Damien Vitour;Damien Vitour;Damien Vitour;Brigitte Solhonne;Brigitte Solhonne

  • FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection

    Thomas Baranek;Thomas Baranek;Eric Morello;Eric Morello;Alexandre Valayer;Alexandre Valayer;Rose-France Aimar;Rose-France Aimar

Frequent Co-Authors

Michel Chignard
Michel Chignard Institut Pasteur
Viviane Balloy
Viviane Balloy Sorbonne University
Reuben Ramphal
Reuben Ramphal University of Florida
James L. Madara
James L. Madara American Medical Association
François Trottein
François Trottein Institut Pasteur
Shanthi V. Sitaraman
Shanthi V. Sitaraman Emory University
Philippe Gosset
Philippe Gosset Institut Pasteur
Didier Merlin
Didier Merlin Georgia State University
Gérard Eberl
Gérard Eberl Université Paris Cité
Jean-Michel Sallenave
Jean-Michel Sallenave Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open up diverse career pathways. Accelerated nursing programs provide a fast track into clinical roles, and students often seek absn programs with high acceptance rates to enhance their chances of admission while advancing quickly.

If you are considering entry-level nursing roles, becoming a Licensed Practical Nurse is a practical step. Many candidates prioritize lpn programs with easiest admission requirements, helping them begin their healthcare career efficiently.

For advanced practice, nurse practitioner degrees offer specialized knowledge that complements immunological expertise. Prospective students often explore nurse practitioner programs with easy admission to streamline their educational journey and qualify for leadership roles in healthcare.

Mental health is another critical area intersecting with immunology, especially in integrative care settings. Those focusing on psychiatric mental health can benefit from researching top pmhnp programs, which offer strong clinical placements essential for hands-on experience.

Best Scientists Citing Mustapha Si-Tahar

Trending Scientists

Recently Published Articles